Review



abcb6  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Boster Bio abcb6
    Sulfur compounds inhibit LPS-induced inflammation and iron/heme metabolism. (A) Flow cytometry showing Fe2+ levels in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. Western blot analysis of (B) transferrin receptor, ferroportin, DMT1 and STEAP3; and (C) MFRN, <t>ABCB6,</t> ABCB10, ALAS1, HO-1, FECH and FLVCR proteins in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. ALAS1, 5′-aminolevulinate synthase 1; DMT1, divalent metal transporter 1; Fe2+, ferrous ion; FECH, ferrochelatase; FPN, ferroportin; HO-1, heme oxygenase-1; LPS, lipopolysaccharide; MFRN, mitoferrin; MSM, methylsulfonylmethane; NTS, nontoxic sulfur; TfR, transferrin receptor; TLR, Toll-like receptor.
    Abcb6, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/abcb6/product/Boster Bio
    Average 90 stars, based on 2 article reviews
    abcb6 - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Understanding the role of iron/heme metabolism in the anti‑inflammatory effects of natural sulfur molecules against lipopolysaccharide‑induced inflammation"

    Article Title: Understanding the role of iron/heme metabolism in the anti‑inflammatory effects of natural sulfur molecules against lipopolysaccharide‑induced inflammation

    Journal: Molecular Medicine Reports

    doi: 10.3892/mmr.2025.13542

    Sulfur compounds inhibit LPS-induced inflammation and iron/heme metabolism. (A) Flow cytometry showing Fe2+ levels in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. Western blot analysis of (B) transferrin receptor, ferroportin, DMT1 and STEAP3; and (C) MFRN, ABCB6, ABCB10, ALAS1, HO-1, FECH and FLVCR proteins in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. ALAS1, 5′-aminolevulinate synthase 1; DMT1, divalent metal transporter 1; Fe2+, ferrous ion; FECH, ferrochelatase; FPN, ferroportin; HO-1, heme oxygenase-1; LPS, lipopolysaccharide; MFRN, mitoferrin; MSM, methylsulfonylmethane; NTS, nontoxic sulfur; TfR, transferrin receptor; TLR, Toll-like receptor.
    Figure Legend Snippet: Sulfur compounds inhibit LPS-induced inflammation and iron/heme metabolism. (A) Flow cytometry showing Fe2+ levels in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. Western blot analysis of (B) transferrin receptor, ferroportin, DMT1 and STEAP3; and (C) MFRN, ABCB6, ABCB10, ALAS1, HO-1, FECH and FLVCR proteins in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. ALAS1, 5′-aminolevulinate synthase 1; DMT1, divalent metal transporter 1; Fe2+, ferrous ion; FECH, ferrochelatase; FPN, ferroportin; HO-1, heme oxygenase-1; LPS, lipopolysaccharide; MFRN, mitoferrin; MSM, methylsulfonylmethane; NTS, nontoxic sulfur; TfR, transferrin receptor; TLR, Toll-like receptor.

    Techniques Used: Flow Cytometry, Western Blot



    Similar Products

    94
    Thermo Fisher gene exp abcb6 mm00470049 m1
    Gene Exp Abcb6 Mm00470049 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene exp abcb6 mm00470049 m1/product/Thermo Fisher
    Average 94 stars, based on 1 article reviews
    gene exp abcb6 mm00470049 m1 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Boster Bio abcb6
    Sulfur compounds inhibit LPS-induced inflammation and iron/heme metabolism. (A) Flow cytometry showing Fe2+ levels in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. Western blot analysis of (B) transferrin receptor, ferroportin, DMT1 and STEAP3; and (C) MFRN, <t>ABCB6,</t> ABCB10, ALAS1, HO-1, FECH and FLVCR proteins in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. ALAS1, 5′-aminolevulinate synthase 1; DMT1, divalent metal transporter 1; Fe2+, ferrous ion; FECH, ferrochelatase; FPN, ferroportin; HO-1, heme oxygenase-1; LPS, lipopolysaccharide; MFRN, mitoferrin; MSM, methylsulfonylmethane; NTS, nontoxic sulfur; TfR, transferrin receptor; TLR, Toll-like receptor.
    Abcb6, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/abcb6/product/Boster Bio
    Average 90 stars, based on 1 article reviews
    abcb6 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    93
    Proteintech anti abcb6 primary antibody
    Sulfur compounds inhibit LPS-induced inflammation and iron/heme metabolism. (A) Flow cytometry showing Fe2+ levels in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. Western blot analysis of (B) transferrin receptor, ferroportin, DMT1 and STEAP3; and (C) MFRN, <t>ABCB6,</t> ABCB10, ALAS1, HO-1, FECH and FLVCR proteins in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. ALAS1, 5′-aminolevulinate synthase 1; DMT1, divalent metal transporter 1; Fe2+, ferrous ion; FECH, ferrochelatase; FPN, ferroportin; HO-1, heme oxygenase-1; LPS, lipopolysaccharide; MFRN, mitoferrin; MSM, methylsulfonylmethane; NTS, nontoxic sulfur; TfR, transferrin receptor; TLR, Toll-like receptor.
    Anti Abcb6 Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti abcb6 primary antibody/product/Proteintech
    Average 93 stars, based on 1 article reviews
    anti abcb6 primary antibody - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Proteintech anti abcb6
    Sulfur compounds inhibit LPS-induced inflammation and iron/heme metabolism. (A) Flow cytometry showing Fe2+ levels in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. Western blot analysis of (B) transferrin receptor, ferroportin, DMT1 and STEAP3; and (C) MFRN, <t>ABCB6,</t> ABCB10, ALAS1, HO-1, FECH and FLVCR proteins in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. ALAS1, 5′-aminolevulinate synthase 1; DMT1, divalent metal transporter 1; Fe2+, ferrous ion; FECH, ferrochelatase; FPN, ferroportin; HO-1, heme oxygenase-1; LPS, lipopolysaccharide; MFRN, mitoferrin; MSM, methylsulfonylmethane; NTS, nontoxic sulfur; TfR, transferrin receptor; TLR, Toll-like receptor.
    Anti Abcb6, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti abcb6/product/Proteintech
    Average 93 stars, based on 1 article reviews
    anti abcb6 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Proteintech abc
    Sulfur compounds inhibit LPS-induced inflammation and iron/heme metabolism. (A) Flow cytometry showing Fe2+ levels in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. Western blot analysis of (B) transferrin receptor, ferroportin, DMT1 and STEAP3; and (C) MFRN, <t>ABCB6,</t> ABCB10, ALAS1, HO-1, FECH and FLVCR proteins in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. ALAS1, 5′-aminolevulinate synthase 1; DMT1, divalent metal transporter 1; Fe2+, ferrous ion; FECH, ferrochelatase; FPN, ferroportin; HO-1, heme oxygenase-1; LPS, lipopolysaccharide; MFRN, mitoferrin; MSM, methylsulfonylmethane; NTS, nontoxic sulfur; TfR, transferrin receptor; TLR, Toll-like receptor.
    Abc, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/abc/product/Proteintech
    Average 93 stars, based on 1 article reviews
    abc - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Proteintech yap1
    Sulfur compounds inhibit LPS-induced inflammation and iron/heme metabolism. (A) Flow cytometry showing Fe2+ levels in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. Western blot analysis of (B) transferrin receptor, ferroportin, DMT1 and STEAP3; and (C) MFRN, <t>ABCB6,</t> ABCB10, ALAS1, HO-1, FECH and FLVCR proteins in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. ALAS1, 5′-aminolevulinate synthase 1; DMT1, divalent metal transporter 1; Fe2+, ferrous ion; FECH, ferrochelatase; FPN, ferroportin; HO-1, heme oxygenase-1; LPS, lipopolysaccharide; MFRN, mitoferrin; MSM, methylsulfonylmethane; NTS, nontoxic sulfur; TfR, transferrin receptor; TLR, Toll-like receptor.
    Yap1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/yap1/product/Proteintech
    Average 93 stars, based on 1 article reviews
    yap1 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    GenScript corporation abcb6 antibody
    a DUH mutations occur in highly conserved regions of <t>ABCB6,</t> as shown in alignments with Pan troglodytes (chimpanzee, 99.5% identity), Mus musculus (mouse, 89.0% identity), and Danio rerio (zebrafish, 63.6% identity). All percent identities are compared to the human ABCB6. b Western blot shows most DUH mutations express similarly to ABCB6 WT (representative data shown). c Band signals from ( b ) and replicates show statistically significant reduction in expression level of S170G, S322R, and L356P ( p = 0.020, < 0.0001, and < 0.0001, respectively, from unpaired two-tailed Welch’s T-test compared to ABCB6 WT). Data reported as mean ± SEM, N = 5 biological replicates. Western blots show DUH mutants bind ATP-agarose ( d ) and hemin-agarose ( e ) comparably to ABCB6 WT. f Quantitation of Western blot signals from ATP- and hemin-agarose pulldowns ( d , e ) and replicates show DUH mutants bind ATP-agarose and hemin-agarose comparably to ABCB6 WT. Percent of WT binding was calculated as described in Supplementary Methods. No signal of L356P could be detected in the ATP-agarose eluted fraction ( d ), but a faint band could be detected from the hemin-agarose elution fraction ( e ). No difference compared to ABCB6 WT was found by unpaired two-tailed Welch’s T-test for any of the mutants binding to hemin-agarose. L356P showed a statistically significant decrease in ATP-agarose binding ( p = 0.0004). Data are reported as mean ± SEM. ATP agarose N = 3 biological replicates, hemin agarose N = 4 biological replicates. Each biological replicate was repeated from transfection to western blot. Source data are provided in the Source Data file.
    Abcb6 Antibody, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/abcb6 antibody/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    abcb6 antibody - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    GenScript corporation custom-developed anti-abcb6
    a DUH mutations occur in highly conserved regions of <t>ABCB6,</t> as shown in alignments with Pan troglodytes (chimpanzee, 99.5% identity), Mus musculus (mouse, 89.0% identity), and Danio rerio (zebrafish, 63.6% identity). All percent identities are compared to the human ABCB6. b Western blot shows most DUH mutations express similarly to ABCB6 WT (representative data shown). c Band signals from ( b ) and replicates show statistically significant reduction in expression level of S170G, S322R, and L356P ( p = 0.020, < 0.0001, and < 0.0001, respectively, from unpaired two-tailed Welch’s T-test compared to ABCB6 WT). Data reported as mean ± SEM, N = 5 biological replicates. Western blots show DUH mutants bind ATP-agarose ( d ) and hemin-agarose ( e ) comparably to ABCB6 WT. f Quantitation of Western blot signals from ATP- and hemin-agarose pulldowns ( d , e ) and replicates show DUH mutants bind ATP-agarose and hemin-agarose comparably to ABCB6 WT. Percent of WT binding was calculated as described in Supplementary Methods. No signal of L356P could be detected in the ATP-agarose eluted fraction ( d ), but a faint band could be detected from the hemin-agarose elution fraction ( e ). No difference compared to ABCB6 WT was found by unpaired two-tailed Welch’s T-test for any of the mutants binding to hemin-agarose. L356P showed a statistically significant decrease in ATP-agarose binding ( p = 0.0004). Data are reported as mean ± SEM. ATP agarose N = 3 biological replicates, hemin agarose N = 4 biological replicates. Each biological replicate was repeated from transfection to western blot. Source data are provided in the Source Data file.
    Custom Developed Anti Abcb6, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/custom-developed anti-abcb6/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    custom-developed anti-abcb6 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Sulfur compounds inhibit LPS-induced inflammation and iron/heme metabolism. (A) Flow cytometry showing Fe2+ levels in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. Western blot analysis of (B) transferrin receptor, ferroportin, DMT1 and STEAP3; and (C) MFRN, ABCB6, ABCB10, ALAS1, HO-1, FECH and FLVCR proteins in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. ALAS1, 5′-aminolevulinate synthase 1; DMT1, divalent metal transporter 1; Fe2+, ferrous ion; FECH, ferrochelatase; FPN, ferroportin; HO-1, heme oxygenase-1; LPS, lipopolysaccharide; MFRN, mitoferrin; MSM, methylsulfonylmethane; NTS, nontoxic sulfur; TfR, transferrin receptor; TLR, Toll-like receptor.

    Journal: Molecular Medicine Reports

    Article Title: Understanding the role of iron/heme metabolism in the anti‑inflammatory effects of natural sulfur molecules against lipopolysaccharide‑induced inflammation

    doi: 10.3892/mmr.2025.13542

    Figure Lengend Snippet: Sulfur compounds inhibit LPS-induced inflammation and iron/heme metabolism. (A) Flow cytometry showing Fe2+ levels in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. Western blot analysis of (B) transferrin receptor, ferroportin, DMT1 and STEAP3; and (C) MFRN, ABCB6, ABCB10, ALAS1, HO-1, FECH and FLVCR proteins in THP-1 cells following treatment with LPS (10 ng/ml) + NTS (3 µg/ml), MSM (200 mM) or TLR-C34 (40 µM) for 48 h. ALAS1, 5′-aminolevulinate synthase 1; DMT1, divalent metal transporter 1; Fe2+, ferrous ion; FECH, ferrochelatase; FPN, ferroportin; HO-1, heme oxygenase-1; LPS, lipopolysaccharide; MFRN, mitoferrin; MSM, methylsulfonylmethane; NTS, nontoxic sulfur; TfR, transferrin receptor; TLR, Toll-like receptor.

    Article Snippet: The following primary antibodies were purchased from Santa Cruz Biotechnology, Inc.: Ferrochelatase (FECH; cat. no. sc-377377), phosphorylated (p)-IκBα (cat. no. sc-8404), TLR2 (cat. no. sc-21759), TLR4 (cat. no. sc-293072), COX-1 (cat. no. sc-19998), COX-2 (cat. no. sc-19999, IKKα/β (cat. no. sc-7607), and β-actin (cat. no. sc-47778); from Cell Signaling Technology, Inc.: IL-1β (cat. no. 12703), p-ERK (cat. no. 9101), ERK (cat. no. 9102), IκBα (cat. no. 9242), p-IKKα/β (cat. no. 2697), NF-κB (cat. no. 8242), p-p38 (cat. no. 4511), p38 (cat. no. 8690), ATR (cat. no. 2790), ATM (cat. no. 2873), Chk2 (cat. no. 2662), BRCA1 (cat. no. 9010), p53 (cat. no. 9282), p-MDM2 (cat. no. 3521), MDM2 (cat. no. 86934) and the DNA Damage Antibody Sampler Kit (cat. no. 9947; containing p-ATM, p-ATR, p-Chk2, p-BRCA1 and p-p53 antibodies); from Abcam: Divalent metal transporter (DMT)1 (cat. no. ab55735), 5′-aminolevulinate synthase (ALAS)1 (cat. no. ab84962), STEAP3 (cat. no. ab151566), HO-1 (cat. no. ab137749), transferrin receptor (TfR; cat. no. ab84036), PKCα (cat. no. ab179523), p-PKCα (cat. no. ab59411), TNF-α (cat. no. ab183218), IL-6 (cat. no. ab6672) and TATA-binding protein (TBP; cat. no. ab818); from LifeSpan BioSciences, Inc.: ABCB10 (cat. no. LS-C381841) and FLVCR1 (cat. no. LS-C750126); from LS Bio; Vector Laboratories, Inc.: FPN (cat. no. NBP1-21502) and iNOS (cat. no. NB300-605); from Novus Biologicals; Bio-Techne: Mitoferrin (MFRN; cat. no. MBS6013473); and from Boster Biological Technology: ABCB6 (cat. no. PA1723).

    Techniques: Flow Cytometry, Western Blot

    a DUH mutations occur in highly conserved regions of ABCB6, as shown in alignments with Pan troglodytes (chimpanzee, 99.5% identity), Mus musculus (mouse, 89.0% identity), and Danio rerio (zebrafish, 63.6% identity). All percent identities are compared to the human ABCB6. b Western blot shows most DUH mutations express similarly to ABCB6 WT (representative data shown). c Band signals from ( b ) and replicates show statistically significant reduction in expression level of S170G, S322R, and L356P ( p = 0.020, < 0.0001, and < 0.0001, respectively, from unpaired two-tailed Welch’s T-test compared to ABCB6 WT). Data reported as mean ± SEM, N = 5 biological replicates. Western blots show DUH mutants bind ATP-agarose ( d ) and hemin-agarose ( e ) comparably to ABCB6 WT. f Quantitation of Western blot signals from ATP- and hemin-agarose pulldowns ( d , e ) and replicates show DUH mutants bind ATP-agarose and hemin-agarose comparably to ABCB6 WT. Percent of WT binding was calculated as described in Supplementary Methods. No signal of L356P could be detected in the ATP-agarose eluted fraction ( d ), but a faint band could be detected from the hemin-agarose elution fraction ( e ). No difference compared to ABCB6 WT was found by unpaired two-tailed Welch’s T-test for any of the mutants binding to hemin-agarose. L356P showed a statistically significant decrease in ATP-agarose binding ( p = 0.0004). Data are reported as mean ± SEM. ATP agarose N = 3 biological replicates, hemin agarose N = 4 biological replicates. Each biological replicate was repeated from transfection to western blot. Source data are provided in the Source Data file.

    Journal: Nature Communications

    Article Title: The role of ATP-binding Cassette subfamily B member 6 in the inner ear

    doi: 10.1038/s41467-024-53663-x

    Figure Lengend Snippet: a DUH mutations occur in highly conserved regions of ABCB6, as shown in alignments with Pan troglodytes (chimpanzee, 99.5% identity), Mus musculus (mouse, 89.0% identity), and Danio rerio (zebrafish, 63.6% identity). All percent identities are compared to the human ABCB6. b Western blot shows most DUH mutations express similarly to ABCB6 WT (representative data shown). c Band signals from ( b ) and replicates show statistically significant reduction in expression level of S170G, S322R, and L356P ( p = 0.020, < 0.0001, and < 0.0001, respectively, from unpaired two-tailed Welch’s T-test compared to ABCB6 WT). Data reported as mean ± SEM, N = 5 biological replicates. Western blots show DUH mutants bind ATP-agarose ( d ) and hemin-agarose ( e ) comparably to ABCB6 WT. f Quantitation of Western blot signals from ATP- and hemin-agarose pulldowns ( d , e ) and replicates show DUH mutants bind ATP-agarose and hemin-agarose comparably to ABCB6 WT. Percent of WT binding was calculated as described in Supplementary Methods. No signal of L356P could be detected in the ATP-agarose eluted fraction ( d ), but a faint band could be detected from the hemin-agarose elution fraction ( e ). No difference compared to ABCB6 WT was found by unpaired two-tailed Welch’s T-test for any of the mutants binding to hemin-agarose. L356P showed a statistically significant decrease in ATP-agarose binding ( p = 0.0004). Data are reported as mean ± SEM. ATP agarose N = 3 biological replicates, hemin agarose N = 4 biological replicates. Each biological replicate was repeated from transfection to western blot. Source data are provided in the Source Data file.

    Article Snippet: The supernatant (20 μL) was subjected to immunoblot analysis using an ABCB6 antibody (Genescript custom-developed Anti-ABCB6, rabbit 2° antibody).

    Techniques: Western Blot, Expressing, Two Tailed Test, Quantitation Assay, Binding Assay, Transfection

    a Western blot shows L356P is disproportionately stabilized by 4-phenylbutyrate (4-PBA) compared to ABCB6 WT. MG132 and chloroquine (CQ) also show a less significant effect on expression (representative data shown). b Band signals from ( a ) and replicates were quantitated and the percentage of untreated signal was calculated (see Supplementary Methods). ABCB6 WT is shown in indigo, L356P is shown in magenta. Analysis using an unpaired two-tailed Welch’s T-test and found no significant differences between ABCB6 WT and L356P except for with 4-PBA treatment ( p = 0.00262, N = 3 biological replicates per treatment.) Data are reported as mean ± SEM. c L356P (magenta) has significantly decreased ATPase activity compared to ABCB6 WT (indigo). The catalytically inactive E752Q mutant is shown in grey. Data are reported as mean ± SEM, N = 15 experiments for ABCB6 WT from five biological replicates, N = 8 experiments for E752Q from three biological replicates, and N = 4 for L356P from two biological replicates. d Western blot of isothermal shift assay shows L356P exhibits little thermal stabilization with AMP-PNP treatment, suggesting L356P cannot interact with ATP (representative data shown). e Band signals from (d) and replicates were quantitated. Data are reported as mean ± SEM. N = 3 technical replicates for ABCB6 WT (indigo) and L356P (magenta). f Cryo-EM structure of ABCB6 WT (EMDB ID: EMD-46724, PDB ID: 9DBQ) and resulting cartoon model ( g ). Nucleotide binding domains (NBDs) are shown in darker tones while transmembrane domains (TMDs) are colored in lighter tones. L356 (orange) is located near the coupling helix of ABCB6 (inset). Predominant conformations of ABCB6 WT ( h ) and L356P ( i ) over the combined 1500 ns of MD simulation as selected from hierarchical agglomerative clustering analysis ( j ) Overlay of ABCB6 WT (purple) and L356P (pink) showing the change in conformation of the coupling helix. A single chain of the homodimer has been shown for clarity, however similar changes are observed in both monomers. Overlay of ATP from ABCB10 (PDB ID: 4AYT) onto ABCB6 WT ( k ) or L356P ( l ) showing the change in conformation of the ATP binding site. Source data are provided in the Source Data file.

    Journal: Nature Communications

    Article Title: The role of ATP-binding Cassette subfamily B member 6 in the inner ear

    doi: 10.1038/s41467-024-53663-x

    Figure Lengend Snippet: a Western blot shows L356P is disproportionately stabilized by 4-phenylbutyrate (4-PBA) compared to ABCB6 WT. MG132 and chloroquine (CQ) also show a less significant effect on expression (representative data shown). b Band signals from ( a ) and replicates were quantitated and the percentage of untreated signal was calculated (see Supplementary Methods). ABCB6 WT is shown in indigo, L356P is shown in magenta. Analysis using an unpaired two-tailed Welch’s T-test and found no significant differences between ABCB6 WT and L356P except for with 4-PBA treatment ( p = 0.00262, N = 3 biological replicates per treatment.) Data are reported as mean ± SEM. c L356P (magenta) has significantly decreased ATPase activity compared to ABCB6 WT (indigo). The catalytically inactive E752Q mutant is shown in grey. Data are reported as mean ± SEM, N = 15 experiments for ABCB6 WT from five biological replicates, N = 8 experiments for E752Q from three biological replicates, and N = 4 for L356P from two biological replicates. d Western blot of isothermal shift assay shows L356P exhibits little thermal stabilization with AMP-PNP treatment, suggesting L356P cannot interact with ATP (representative data shown). e Band signals from (d) and replicates were quantitated. Data are reported as mean ± SEM. N = 3 technical replicates for ABCB6 WT (indigo) and L356P (magenta). f Cryo-EM structure of ABCB6 WT (EMDB ID: EMD-46724, PDB ID: 9DBQ) and resulting cartoon model ( g ). Nucleotide binding domains (NBDs) are shown in darker tones while transmembrane domains (TMDs) are colored in lighter tones. L356 (orange) is located near the coupling helix of ABCB6 (inset). Predominant conformations of ABCB6 WT ( h ) and L356P ( i ) over the combined 1500 ns of MD simulation as selected from hierarchical agglomerative clustering analysis ( j ) Overlay of ABCB6 WT (purple) and L356P (pink) showing the change in conformation of the coupling helix. A single chain of the homodimer has been shown for clarity, however similar changes are observed in both monomers. Overlay of ATP from ABCB10 (PDB ID: 4AYT) onto ABCB6 WT ( k ) or L356P ( l ) showing the change in conformation of the ATP binding site. Source data are provided in the Source Data file.

    Article Snippet: The supernatant (20 μL) was subjected to immunoblot analysis using an ABCB6 antibody (Genescript custom-developed Anti-ABCB6, rabbit 2° antibody).

    Techniques: Western Blot, Expressing, Two Tailed Test, Activity Assay, Mutagenesis, Shift Assay, Cryo-EM Sample Prep, Binding Assay

    a Alignment of homologous ABCB6 sequences shows zebrafish Abcb6 lacks the N-linked glycosylation site . b Western blot of samples from PNGase F treatment confirms that zebrafish Abcb6 is not a glycoprotein, unlike its human homolog ( N = 1 as experiment is a qualitative confirmation of sequencing data). Western blots show zebrafish Abcb6 binds ATP-agarose ( c ) and various porphyrins like its human homolog ( d ). Representative data shown, N = 3 biological replicates for each pulldown, with each experiment repeated from transfection to western blot. e Overlay of a representative structure from the MD simulations of the zebrafish Abcb6 (green) and ABCB6 WT (indigo/turquoise as shown in Fig. ) showing that the two proteins adopt a similar conformation. f Overlay of zebrafish Abcb6 WT and zebrafish Abcb6 L356P showing the change in conformation of the coupling helix. Source data are provided in the Source Data file.

    Journal: Nature Communications

    Article Title: The role of ATP-binding Cassette subfamily B member 6 in the inner ear

    doi: 10.1038/s41467-024-53663-x

    Figure Lengend Snippet: a Alignment of homologous ABCB6 sequences shows zebrafish Abcb6 lacks the N-linked glycosylation site . b Western blot of samples from PNGase F treatment confirms that zebrafish Abcb6 is not a glycoprotein, unlike its human homolog ( N = 1 as experiment is a qualitative confirmation of sequencing data). Western blots show zebrafish Abcb6 binds ATP-agarose ( c ) and various porphyrins like its human homolog ( d ). Representative data shown, N = 3 biological replicates for each pulldown, with each experiment repeated from transfection to western blot. e Overlay of a representative structure from the MD simulations of the zebrafish Abcb6 (green) and ABCB6 WT (indigo/turquoise as shown in Fig. ) showing that the two proteins adopt a similar conformation. f Overlay of zebrafish Abcb6 WT and zebrafish Abcb6 L356P showing the change in conformation of the coupling helix. Source data are provided in the Source Data file.

    Article Snippet: The supernatant (20 μL) was subjected to immunoblot analysis using an ABCB6 antibody (Genescript custom-developed Anti-ABCB6, rabbit 2° antibody).

    Techniques: Glycoproteomics, Western Blot, Sequencing, Transfection

    a Whole mount in situ hybridization (WISH) of 3 dpf AB zebrafish shows Abcb6 expression in the inner ear when treated with a zebrafish abcb6 anti-sense mRNA probe (i-iii). The auditory vesicle is denoted with black arrows. Zebrafish Abcb6 expression is not detected with a zebrafish abcb6 sense mRNA probe (iv). b Zebrafish Abcb6 MO15 morphants (purple) developed a reduced number of hair cells compared to WT (indigo) in zebrafish neuromasts. Data were analyzed by 2-way ANOVA with genotype and neuromast as factors. There is a significant main effect of genotype (F 1,111 = 126.6, p < 0.0001) and neuromast (F 6,111 = 6.13, p < 0.0001). O1, O2, and MI2 neuromasts are found on the head, P1 and P2 represent the first two neuromasts of the posterior lateral line (trunk), and T1 and T2 are the two terminal-most neuromasts on the tail (neuromast nomenclature modified from Raible and Kruse, 2000) . Hair cell counts are from 3 dpf brn3c transgenic larvae, N = 8 fish for uninjected, N = 9 fish for Abcb6 MO15, bars represent mean + 1 SEM. The person counting hair cells was blinded to treatment. Experiment was repeated and the results showed the same pattern. Source data from ( b ) are provided in the Source Data file.

    Journal: Nature Communications

    Article Title: The role of ATP-binding Cassette subfamily B member 6 in the inner ear

    doi: 10.1038/s41467-024-53663-x

    Figure Lengend Snippet: a Whole mount in situ hybridization (WISH) of 3 dpf AB zebrafish shows Abcb6 expression in the inner ear when treated with a zebrafish abcb6 anti-sense mRNA probe (i-iii). The auditory vesicle is denoted with black arrows. Zebrafish Abcb6 expression is not detected with a zebrafish abcb6 sense mRNA probe (iv). b Zebrafish Abcb6 MO15 morphants (purple) developed a reduced number of hair cells compared to WT (indigo) in zebrafish neuromasts. Data were analyzed by 2-way ANOVA with genotype and neuromast as factors. There is a significant main effect of genotype (F 1,111 = 126.6, p < 0.0001) and neuromast (F 6,111 = 6.13, p < 0.0001). O1, O2, and MI2 neuromasts are found on the head, P1 and P2 represent the first two neuromasts of the posterior lateral line (trunk), and T1 and T2 are the two terminal-most neuromasts on the tail (neuromast nomenclature modified from Raible and Kruse, 2000) . Hair cell counts are from 3 dpf brn3c transgenic larvae, N = 8 fish for uninjected, N = 9 fish for Abcb6 MO15, bars represent mean + 1 SEM. The person counting hair cells was blinded to treatment. Experiment was repeated and the results showed the same pattern. Source data from ( b ) are provided in the Source Data file.

    Article Snippet: The supernatant (20 μL) was subjected to immunoblot analysis using an ABCB6 antibody (Genescript custom-developed Anti-ABCB6, rabbit 2° antibody).

    Techniques: In Situ Hybridization, Expressing, Modification, Transgenic Assay

    a Zebrafish Abcb6 MO15 disrupts formation of the utricular otolith (black arrow), while uninjected controls retain both utricular (black arrow) and saccular (white arrow) otoliths at 1-, 5-, and 14-days post-fertilization (dpf). b Uninjected wild-type fish with AB (i) and p53-null (iii) backgrounds develop normal otoliths, while Abcb6 morphants (ii and iv) fail to develop the utricular otolith. c The single otolith phenotype can be rescued by co-injection with human ABCB6 mRNA. Data for uninjected control ( N = 25 fish), zebrafish abcb6 mRNA ( N = 9 fish), Abcb6 MO15 ( N = 20 fish), and Abcb6 MO15 + human ABCB6 mRNA ( N = 19 fish) can be found in Supplementary Table or the source data file. Injections were repeated and the results showed the same pattern.

    Journal: Nature Communications

    Article Title: The role of ATP-binding Cassette subfamily B member 6 in the inner ear

    doi: 10.1038/s41467-024-53663-x

    Figure Lengend Snippet: a Zebrafish Abcb6 MO15 disrupts formation of the utricular otolith (black arrow), while uninjected controls retain both utricular (black arrow) and saccular (white arrow) otoliths at 1-, 5-, and 14-days post-fertilization (dpf). b Uninjected wild-type fish with AB (i) and p53-null (iii) backgrounds develop normal otoliths, while Abcb6 morphants (ii and iv) fail to develop the utricular otolith. c The single otolith phenotype can be rescued by co-injection with human ABCB6 mRNA. Data for uninjected control ( N = 25 fish), zebrafish abcb6 mRNA ( N = 9 fish), Abcb6 MO15 ( N = 20 fish), and Abcb6 MO15 + human ABCB6 mRNA ( N = 19 fish) can be found in Supplementary Table or the source data file. Injections were repeated and the results showed the same pattern.

    Article Snippet: The supernatant (20 μL) was subjected to immunoblot analysis using an ABCB6 antibody (Genescript custom-developed Anti-ABCB6, rabbit 2° antibody).

    Techniques: Injection, Control

    Zebrafish movement paths overlaid with last video frame shows uninjected zebrafish swim smoothly in the upper 2/3 of the tank ( a ), while the zebrafish Abcb6 MO15 morphants swim erratically and spend a significant amount of time in the lower third of the tank ( b ). Abcb6 MO15 morphants (purple) swam further with each video frame ( c ), p = < 0.0001, and swam farther from their starting position ( d ), p = 0.013, than the uninjected controls (indigo). Abcb6 MO15 morphants also swam longer routes than their uninjected counterparts ( e ), p = 0.0176, and spent a significantly higher percentage of time in the bottom of their tank (39.9%) compared to the uninjected control (1.2%) ( f ), p = < 0.0001). Although there was no significant difference in total horizontal distance traveled ( g ) p = 0.0785, Abcb6 MO15 morphants traveled a greater vertical distance (160.7 pixels) than their uninjected controls (79.7 pixels, ( h ), p = 0.0041. * = p < 0.05, ** = p < 0.01, **** = p < 0.0001, ns = not significant by unpaired two-tailed Welch’s T-test compared to uninjected control. Data from 21 dpf AB zebrafish, N = 18 fish for uninjected, N = 25 fish for Abcb6 MO15. Median is shown as a dashed line and upper and lower quartiles are shown as dotted lines. Source data are provided in the Source Data file.

    Journal: Nature Communications

    Article Title: The role of ATP-binding Cassette subfamily B member 6 in the inner ear

    doi: 10.1038/s41467-024-53663-x

    Figure Lengend Snippet: Zebrafish movement paths overlaid with last video frame shows uninjected zebrafish swim smoothly in the upper 2/3 of the tank ( a ), while the zebrafish Abcb6 MO15 morphants swim erratically and spend a significant amount of time in the lower third of the tank ( b ). Abcb6 MO15 morphants (purple) swam further with each video frame ( c ), p = < 0.0001, and swam farther from their starting position ( d ), p = 0.013, than the uninjected controls (indigo). Abcb6 MO15 morphants also swam longer routes than their uninjected counterparts ( e ), p = 0.0176, and spent a significantly higher percentage of time in the bottom of their tank (39.9%) compared to the uninjected control (1.2%) ( f ), p = < 0.0001). Although there was no significant difference in total horizontal distance traveled ( g ) p = 0.0785, Abcb6 MO15 morphants traveled a greater vertical distance (160.7 pixels) than their uninjected controls (79.7 pixels, ( h ), p = 0.0041. * = p < 0.05, ** = p < 0.01, **** = p < 0.0001, ns = not significant by unpaired two-tailed Welch’s T-test compared to uninjected control. Data from 21 dpf AB zebrafish, N = 18 fish for uninjected, N = 25 fish for Abcb6 MO15. Median is shown as a dashed line and upper and lower quartiles are shown as dotted lines. Source data are provided in the Source Data file.

    Article Snippet: The supernatant (20 μL) was subjected to immunoblot analysis using an ABCB6 antibody (Genescript custom-developed Anti-ABCB6, rabbit 2° antibody).

    Techniques: Control, Two Tailed Test

    a mRNA counts of mouse Abcb6 increase with cochlear development (white), but not utricular development (black). Data taken from the SHIELD database . b 5–6-week-old Abcb6 knockout (KO) mice (purple) exhibit a frequency-independent increase in auditory brainstem response (ABR) compared to the wild-type control (indigo). Data are reported as mean ± SEM. N = 5 mice for WT Control (C57/129 mix) and N = 6 mice for Abcb6 KO. Source data are provided in the Source Data file.

    Journal: Nature Communications

    Article Title: The role of ATP-binding Cassette subfamily B member 6 in the inner ear

    doi: 10.1038/s41467-024-53663-x

    Figure Lengend Snippet: a mRNA counts of mouse Abcb6 increase with cochlear development (white), but not utricular development (black). Data taken from the SHIELD database . b 5–6-week-old Abcb6 knockout (KO) mice (purple) exhibit a frequency-independent increase in auditory brainstem response (ABR) compared to the wild-type control (indigo). Data are reported as mean ± SEM. N = 5 mice for WT Control (C57/129 mix) and N = 6 mice for Abcb6 KO. Source data are provided in the Source Data file.

    Article Snippet: The supernatant (20 μL) was subjected to immunoblot analysis using an ABCB6 antibody (Genescript custom-developed Anti-ABCB6, rabbit 2° antibody).

    Techniques: Knock-Out, Control